An open-label trial of olanzapine for corticosteroid-induced mood symptoms

被引：1
|
作者：
Brown, ES
Chamberlain, W
Dhanani, N
Paranjpe, P
Sargeant, M
机构：
来源：
PSYCHOSOMATICS | 2004年 / 45卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [41] Psychiataric symptoms among outpatients in an open-label trial of risperidone for methamphetamine dependence
    Jaffe, C
    Saxon, AJ
    Meredith, CW
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S146 - S146
  • [42] Open-Label Placebos Improve Symptoms in Allergic Rhinitis: A Randomized Controlled Trial
    Schaefer, Michael
    Harke, Rebecca
    Denke, Claudia
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2016, 85 (06) : 373 - 374
  • [43] An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia
    Lopes Rocha, Fabio
    Hara, Claudia
    Guarieiro Ramos, Melissa
    Guimaraes Kascher, Gustavo
    Antunes Santos, Milena
    de Oliveira Lanca, Gleida
    Magalhaes Scoralick, Francisca
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2006, 22 (5-6) : 445 - 448
  • [44] An open-label study of olanzapine in the first episode of schizophrenia in adolescents
    Dabokowska, M
    EUROPEAN PSYCHIATRY, 2002, 17 : 115S - 115S
  • [45] An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients
    Solaro, C
    Lunardi, GL
    Capello, E
    Inglese, M
    Uccelli, MM
    Uccelli, A
    Mancardi, GL
    NEUROLOGY, 1998, 51 (02) : 609 - 611
  • [46] Open-label maintenance treatment for bipolar depression using olanzapine or olanzapine/fluoxetine combination
    Ketter, TA
    Tohen, M
    Vieta, E
    Calabrese, J
    Andersen, SW
    Detke, HC
    Risser, R
    Corya, SA
    BIPOLAR DISORDERS, 2004, 6 : 27 - 27
  • [47] Effects of yokukansan on behavioral and psychological symptoms of vascular dementia: An open-label trial
    Nagata, Ken
    Yokoyama, Eriko
    Yamazaki, Takashi
    Takano, Daiki
    Maeda, Tetsuya
    Takahashi, Satoshi
    Terayama, Yasuo
    PHYTOMEDICINE, 2012, 19 (06) : 524 - 528
  • [48] Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced vomiting in children: An open-label, randomized phase 3 trial
    Radhakrishnan, Venkatraman
    Pai, Vishwajeeth
    Rajaraman, Swaminathan
    Mehra, Nikita
    Ganesan, Trivadi
    Dhanushkodi, Manikandan
    Perumal Kalaiyarasi, Jayachandran
    Rajan, Arun Kumar
    Selvarajan, Gangothri
    Ranganathan, Rama
    Karunakaran, Parathan
    Sagar, Tenali G.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (09)
  • [49] Olanzapine Versus Metoclopramide for the Treatment of Breakthrough Chemotherapy-Induced Vomiting in Children: An Open-Label, Randomized Phase 3 Trial
    Radhakrishnan, V.
    Pai, V.
    Rajaraman, S.
    Mehra, N.
    Ganesan, T.
    Dhanushkodi, M.
    Kalaiarasi, J. Perumal
    Kumar, A.
    Selvarajan, G.
    Renganathan, R.
    Sagar, T.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S1 - S1
  • [50] Use of montelukast in tapering inhaled corticosteroid therapy: An open-label, 48-week trial
    Price, DB
    Rouleau, MY
    Fletcher, CP
    Patel, P
    Olivenstein, R
    Myhr, L
    Virchow, JC
    Aitchison, WRC
    Omenaas, ER
    Dellea, PS
    Laurenzi, M
    Leff, JA
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2001, 62 (11): : 743 - 755
12345